poisar

Stocks · News reference

Argus Research Reiterates Buy on Corteva, Maintains $91 Price Target

BenzingaBenzinga Newsdesk

Argus Research analyst Alexandra Yates reiterates Corteva (NYSE:CTVA) with a Buy and maintains $91 price target.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Corteva, Inc. (CTVA)

    Filed: 2026-09-25 AccNo: 0001193125-26-401618 Size: 213 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

  2. Zacks Investment ResearchNa

    Mission Produce's Blueberry Business: A Hidden Opportunity?

    Mission Produce's blueberry segment is expanding with Q3 sales rising to $5.4M from $4.5M year-over-year, though currently unprofitable due to seasonality. The company expects stronger Q4 performance as the seasonal ramp begins. Meanwhile, Corteva benefits from innovation-driven agricultural demand, while Dole faces margin pressures from elevated input costs and supply chain challenges, partially offset by strong diversified produce performance.